•  Retrait gratuit dans votre magasin Club
  •  7.000.000 titres dans notre catalogue
  •  Payer en toute sécurité
  •  Toujours un magasin près de chez vous     
  •  Retrait gratuit dans votre magasin Club
  •  7.000.000 titres dans notre catalogue
  •  Payer en toute sécurité
  •  Toujours un magasin près de chez vous

Diagnostic Pathology: Molecular Oncology

Mohammad A Vasef, Aaron Auerbach
Livre relié | Anglais | Diagnostic Pathology
349,45 €
+ 698 points
Format
Livraison 1 à 2 semaines
Passer une commande en un clic
Payer en toute sécurité
Livraison en Belgique: 3,99 €
Livraison en magasin gratuite

Description

Covering all aspects of molecular pathology as it relates to the transformation and pathogenesis of cancer, this award-winning volume in the Diagnostic Pathology series is an expert resource for pathologists at all levels of experience and training, both as a quick reference and as an efficient review to improve knowledge and skills. This easily accessible, point-of-care reference features templated, bulleted content that is generously illustrated with charts, graphs, tables, and color photomicrographs of histology with special stains. It offers a practical, clinical approach to examining how molecular mutations affect common medical diseases and identifies the relevant and appropriate molecular tests to perform for a complete work-up in the era of molecular-targeted therapies.

  • Provides updated information on molecular mutations in different tumors, including solid tumors and hematopoietic neoplasms, and new targeted therapies geared toward these molecular alterations
  • Discusses now widely used immunotherapy treatments, including how immunotherapy has revolutionized the treatment of many neoplasms such as breast and lung carcinomas and lymphoma
  • Features more than 2,000 annotated images throughout, including H&E stains, immunostains, and FISH images
  • Covers timely topics such as:
    • Recent advances in cancer immunotherapy, specifically in the molecular basis of immunotherapy
    • Newly discovered targeted therapies, including multiple lung carcinoma therapies now considered for patients based on existing mutations to specific genes (KRAS, ALK, BRAF, and ROS)
    • The need for integration of myeloid and lymphoid gene panels due to increased knowledge from next generation sequencing studies of new mutations and the resulting newly developed molecular targets
    • Increased usage of next generation sequencing techniques
    • Changes to hematopoietic tumor details based on revised WHO guidelines

  • Recipient of a 2016 BMA Award: Highly Commended, Pathology (previous edition)
  • Enhanced eBook version included with purchase
  • , which allows you to access all of the text, figures, and references from the book on a variety of devices

Spécifications

Parties prenantes

Auteur(s) :
Editeur:

Contenu

Nombre de pages :
1016
Langue:
Anglais
Collection :

Caractéristiques

EAN:
9780323611442
Date de parution :
31-07-19
Format:
Livre relié
Format numérique:
Genaaid
Dimensions :
226 mm x 282 mm
Poids :
3129 g

Les avis